Concepedia

Publication | Closed Access

Defining Prostate Cancer at Favorable Intermediate Risk: The Potential Utility of Magnetic Resonance Imaging and Genomic Tests

DOI

33

Citations

0

References

2019

Year

Ugo Giovanni Falagario, Alp Tuna Beksaç, Alberto Martini, Shivaram Cumarasamy, Akriti Gupta, Sonya Prasad, Hari Thulasidass, Qainat N. Shah, Isuru Jayaratna, Sara Lewis,
The Journal of Urology

Abstract

Multiparametric magnetic resonance imaging and the Decipher test allowed us to better define the risk of adverse pathology in patients at favorable intermediate risk who were diagnosed with prostate cancer.